Moreover, pre-incubation of a CD36 inhibitor, sulfosuccinimidyl oleate (SSO), also reduced OTA-induced cellular TG accumulation, further confirming that OTA-induced hepatic steatosis was dependent on CD36. Here, CD36 is linked to fatty liver disease.